Objectives:

1. Identify the varying subtypes and prognostic features of CLL that impact treatment decisions.

2. Review literature on chemoimmunotherapy.

3. Understand the patient populations that are better served with targeted therapies.

Session date: 
Thursday, December 8, 2016 - 8:00am to 9:00am
Location: 
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Andrew Hantel, M.D.